These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38480469)

  • 1. Elevated Plasma Lipoprotein(a) Level and Atherosclerotic Cardiovascular Disease Risks: A Large Clinical Retrospective Study.
    Wang K; Wang W; Niu J; Liu X; Han H; Shen H; Sun Y; Gao W; Ge H
    Angiology; 2024 Mar; ():33197241239688. PubMed ID: 38480469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood.
    Raitakari O; Kartiosuo N; Pahkala K; Hutri-Kähönen N; Bazzano LA; Chen W; Urbina EM; Jacobs DR; Sinaiko A; Steinberger J; Burns T; Daniels SR; Venn A; Woo JG; Dwyer T; Juonala M; Viikari J
    Circulation; 2023 Jan; 147(1):23-31. PubMed ID: 36440577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and Increased Cardiovascular Risk in Women.
    Costello BT; Silverman ER; Doukky R; Braun LT; Aggarwal NT; Deng Y; Li Y; Lundberg G; Williams KA; Volgman AS
    Clin Cardiol; 2016 Feb; 39(2):96-102. PubMed ID: 26880352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
    Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M
    J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.
    Mayyas F; Bani Omar E
    Heliyon; 2022 Jul; 8(7):e09836. PubMed ID: 35815138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
    Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients.
    Wang X; Chen X; Wang Y; Peng S; Pi J; Yue J; Meng Q; Liu J; Zheng L; Chan P; Tomlinson B; Liu Z; Zhang Y
    Int J Gen Med; 2023; 16():2805-2817. PubMed ID: 37426518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience.
    Anastasiou G; Sakka E; Blathra E; Kalivi A; Elisaf M; Liamis G; Liberopoulos E
    Arch Med Res; 2021 May; 52(4):397-404. PubMed ID: 33380360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank.
    Welsh P; Al Zabiby A; Byrne H; Benbow HR; Itani T; Farries G; Costa-Scharplatz M; Ferber P; Martin L; Brown R; Fonseca AF; Sattar N
    Atherosclerosis; 2024 Feb; 389():117437. PubMed ID: 38219651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study.
    Hu X; Yang X; Li X; Luo D; Zhou Y; Dong H
    Lipids Health Dis; 2020 Jul; 19(1):173. PubMed ID: 32703301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting.
    Cicero AFG; Fogacci F; Giovannini M; Grandi E; D'Addato S; Borghi C
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
    Iida K; Tani S; Atsumi W; Yagi T; Kawauchi K; Matsumoto N; Hirayama A
    Coron Artery Dis; 2017 Nov; 28(7):577-587. PubMed ID: 28692480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lipoprotein(a) and premature atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Tian X; Zhang N; Tse G; Li G; Sun Y; Liu T
    Eur Heart J Open; 2024 May; 4(3):oeae031. PubMed ID: 38737415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial.
    Li D; Xu T; Xie D; Wang M; Sun S; Wang M; Zhang S; Yang X; Zhang Z; Wang S; Kuang M; Tang J; Liu H; Hong X; Fu G; Zhang W
    J Med Internet Res; 2023 Apr; 25():e44939. PubMed ID: 37043273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.